YERXA BENJAMIN R
SEC CIK 1145910 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | Pres, Dir | 704.1K | $9,800 | $61.2K | 6 | 2024-11-07 | 2026-07-23 |
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-27 16:08 | 2026-07-23 | IRD | Opus Genetics, Inc. | YERXA BENJAMIN R | Pres, Dir | S - Sale | $2.97 | -7,429 | 704.1K | -1% | -$22.1K | |
| 2026-04-27 16:28 | 2026-04-23 | IRD | Opus Genetics, Inc. | YERXA BENJAMIN R | Pres, Dir | S - Sale | $5.24 | -7,470 | 711.5K | -1% | -$39.1K | |
| 2026-01-26 | 2026-01-22 | IRD | Opus Genetics, Inc. | YERXA BENJAMIN R | Pres, Dir | A - Grant | $0.00 | +400.0K | 719.0K | +125% | $0 | |
| 2025-10-24 | 2025-10-22 | IRD | Opus Genetics, Inc. | YERXA BENJAMIN R | Pres, Dir | F - Tax | $1.95 | -23.8K | 319.0K | -7% | -$46.4K | |
| 2024-11-25 | 2024-11-21 | IRD | Opus Genetics, Inc. | YERXA BENJAMIN R | Pres, Dir | P - Purchase | $0.98 | +10.0K | 342.8K | +3% | +$9,800 | |
| 2024-11-12 | 2024-11-07 | IRD | Opus Genetics, Inc. | YERXA BENJAMIN R | Pres, Dir | A - Grant | $0.00 | +332.8K | 332.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations